诚意药业：控股股东的一致行动人累计减持0.77%公司股份

Summary of Key Points Core Viewpoint - Chengyi Pharmaceutical (603811.SH) has reported a significant reduction in shareholding by major shareholders, indicating potential shifts in ownership dynamics within the company [1] Group 1: Shareholding Changes - Ms. Yan Xiaoling has reduced her shareholding by 349,722 shares through centralized bidding [1] - Wenzhou Dongtou Chengyi Microfinance Co., Ltd. has reduced its holdings by 2.1649 million shares through centralized bidding and block trading [1] - The total reduction in shares by these shareholders amounts to 2.5146 million shares, representing 0.77% of the company's total share capital [1] Group 2: Impact on Major Shareholders - Following these transactions, the controlling shareholder Mr. Yan Yiyi and his concerted parties have seen their total shareholding decrease from 81,067,702 shares to 78,553,080 shares [1] - The overall shareholding percentage of these major shareholders has decreased from 24.77% to 24.00%, which triggers a change in equity that touches the 1% threshold [1]